| Literature DB >> 30323649 |
Albert Feliu-Soler1,2, Francisco Montesinos3,4, Olga Gutiérrez-Martínez5, Whitney Scott6, Lance M McCracken6,7, Juan V Luciano1,2.
Abstract
It is well known that chronic pain is prevalent, complex to manage, and associated with high costs, in health care and society in general. Thanks to advances in new forms of cognitive behavioral therapy (known as third-wave CBT), currently clinicians and researchers have an empirically validated psychological treatment with increasing research support for the treatment of chronic pain. This treatment is called acceptance and commitment therapy (ACT). The main aim of this paper is to provide a narrative review that summarizes and integrates the current state of knowledge of ACT in the management of chronic pain as well as discuss current challenges and opportunities for progress. Based on the psychological flexibility model, ACT extends previous forms of CBT and integrates many CBT-related variables into six core therapeutic processes. ACT is a process-based therapy that fosters openness, awareness, and engagement through a wide range of methods, including exposure-based and experiential methods, metaphors, and values clarification. To our knowledge, there are three published systematic reviews and meta-analyses that support the effectiveness of ACT for chronic pain and many studies focused on specific processes derived from the psychological flexibility model. There is also promising support for the cost-effectiveness of ACT; however, the current evidence is still insufficient to establish firm conclusions about cost-effectiveness and the most efficient means of delivery. Additional well-designed economic evaluations are needed. Other research aims include delineating the neurobiological underpinnings of ACT, refining available outcome and process measures or develop new ones for ACT trials, and meeting the challenge of wide dissemination and implementation in real-world clinical practice.Entities:
Keywords: acceptance and commitment therapy; assessment; chronic pain; clinical evidence; cost-effectiveness; review
Year: 2018 PMID: 30323649 PMCID: PMC6174685 DOI: 10.2147/JPR.S144631
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1The hexaflex model of ACT for psychological flexibility and inflexibility.
Abbreviation: ACT, acceptance and commitment therapy.
Example of session outlines for group-based ACT for chronic pain.11
| Session | ACT |
|---|---|
| 1 | The limits of control (short- and long-term costs and benefits; finger traps), focus on experience (body scan) |
| 2 | Values (what you care about, how you want to live your life) |
| 3 | Cognitive defusion (observing thoughts without trying to evaluate or change them) |
| 4 | Mindfulness (being in the moment) |
| 5 | Committed action (connecting values, goals, actions, obstacles, and strategies) |
| 6 | Review and continued action in support of values |
| 7 | Review and continued action in support of values |
| 8 | Moving forward |
Abbreviation: ACT, acceptance and commitment therapy.
Published and upcoming (data extracted from study protocols) economic evaluations of ACT for chronic pain
| Author Year Country | Target condition | Treatment arms (n); Delivery period | Cost categories included (cost-perspective) | Clinical effect or utility outcome | Results of the economic evaluation | Time horizon |
|---|---|---|---|---|---|---|
| Kemani et al | Unspecific, long-standing pain | ACT (n=30) | Analysis from the societal perspective. Data obtained in three different domains: (1) direct medical costs, comprising costs related to health-care utilization, medication use + intervention costs; (2) direct nonmedical costs; and (3) indirect nonmedical costs (employment status, sick leave, and reduced capacity at work and domestically). | PDI | Cost-effectiveness (ITT; societal perspective) ICER at 6 months not reported. No differences in costs or effectiveness between the two treatments. ICER (3 months) = –$648. Each incremental improvement on the PDI for ACT participants relative to AR yielded a societal earning of $648 at 3 months. | 6 months |
| Luciano et al | Fibromyalgia | ACT (n=51) | Analyses performed from the health care (self-reported data collection about medication consumption, medical tests, use of health-related services, and cost of the staff running the ACT intervention) and from a restricted societal perspective (productivity losses). | EQ-5D-3L | Cost–utility analysis (ITT; societal perspective) ICURs not reported. ACT was found to be dominant when compared against RPT and WL. The average incremental cost for the comparison ACT vs RPT was €389.5. The incremental effect for QALYs was found to be around 0.01. | 6 months |
| Hayes et al | Nonmalignant chronic pain | Internet-delivered ACT (n=76) | Societal perspective. Health service use (primary health-care consultations, hospital visits, etc.) and medication use, which is likely to vary throughout the RCT duration, therefore change in medication use (prescribed and over-the-counter) is measured in posttreatment analysis. Record of nonmedical costs related to out-of-pocket expenses (on any treatment not paid by the state, the costs of traveling to, and wait times at, the various health-care services). Costs associated with taking time off work or reduced employment for the patient with chronic pain or for family members who care for the patient. | EQ-5D-5L BPI | Upcoming | 3 months |
| Lin et al | Chronic pain | Guided ACT-based online intervention (“ACTonPain” program); support of an eCoach (n=100) | Societal perspective. Direct and indirect costs are assessed: participants register direct costs (eg, health service uptake or medication). Indirect costs – number of “work loss” days (absenteeism from work) and the number of “work cut-back” days (reduced productivity at work) | EQ-5D-3L | Upcoming | 6 months |
Abbreviations: ACT, acceptance and commitment therapy; AR, applied relaxation; BPI, brief pain inventory; EQ-5D, European Quality of Life (EuroQol) instrument (3L=three-level version; 5L=five-level version); ITT, intent to treat; PDI, Pain Disability Index; RCT, randomized-controlled trial; QALY, quality-adjusted life years; RPT, recommended pharmacological treatment; WL, waiting-list; ICER, Incremental cost-effectiveness ratio; ICUR, Incremental cost-utility ratio.
Source: Adapted from Feliu-Soler et al44